Women-led Egyptian startup Almouneer raises $3.6M to treat diabetes and obesity
- Almouneer, an Egyptian healthtech startup, has raised $3.6 million in seed funding.
- The funding will support the development and expansion of Almouneer's platform for treating diabetes and obesity.
- Almouneer plans to launch patient-customised treatment and nutrition plans, a marketplace for essential consumables, and an app for doctors.
Almouneer's successful seed funding round and ambitious expansion plans demonstrate the growing demand for innovative healthtech solutions. By focusing on chronic diseases like diabetes and obesity, Almouneer has the potential to make a significant impact on healthcare accessibility and affordability. With its patient-centric platform and partnerships with international investors, Almouneer is well-positioned for success in the global healthcare market.
